Handelsavisen
prelaunch
Companies ›Real Estate ›AHR
AH
AHR — NYSE Diversified Specialized REITs

American Healthcare REIT, Inc.

$55,12
Open in Charts → Attach watcher ⌖
— —
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
10,4B USD
P/E
151,8x
EV / Rev
5,0x
Div yield
1,77 %
Op margin
19,8 %
ROE
2,0 %
Net margin
3,3 %
Debt / equity
—
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
$56,38
Open
—
Next earnings
2026-10-28
Ex-dividend
—
TR 1Y
—
About

American Healthcare REIT, Inc. is classified under Real Estate / Real Estate Investment Trusts and appears profitable on the latest normalized snapshot.

Business. American Healthcare REIT, Inc. (NYSE: AHR) is a diversified specialized real estate investment trust that generates revenue primarily through rental income. The company is headquartered in the United States and operates within the healthcare real estate sector. As no specific operating segments or geographic breakdowns are provided, the firm is described at the industry level as a specialized REIT focused on healthcare properties. Its common stock is listed on the New York Stock Exchange under the ticker symbol AHR.

Classification99 %
SectorReal Estate
Industry groupDiversified Specialized REITs
Generated · rules-based
Sell-side consensus
BUY15 analysts
15 buy0 hold0 sell
Avg 12m price target60,07

Analyst recommendations

15 analysts · consensus Buy
Buy15
Hold0
Sell0
12-month price target
60,07
Consensus of sell-side coverage.
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
—
not yet scored
Valuation→
151,8x
P/E
Analysts→
Buy
15 analysts · indicative
Ownership→
Principal Global Investors (Equity)
largest disclosed fund holder
Profitability→
2,0 %
return on equity
Quality
—
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning AHR.

    • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate · THIS SECTOR−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to AHR. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    Briefing · model-assisted

    American Healthcare REIT, Inc. (AHR) experienced a significant fluctuation in its shareholder base, marked by a major holder change involving investor ID 587. This investor initially increased their position from 130 shares to 5,382 shares, a move detected on June 25, 2026, which represented a substantial rise in their portfolio weight. However, this accumulation was short-lived, as the same investor subsequently reduced their holding back to 130 shares, a reversal detected on June 21, 2026. These rapid, opposing adjustments highlight a period of volatility in institutional positioning for the REIT. Concurrently, the company's analytical profile underwent moderate revisions. The AI-driven narrative and conclusion regarding AHR were updated, with a similarity score of 0.546 indicating a notable shift in the underlying thesis. Additionally, the key takeaways associated with the analysis were adjusted, with two points added and two removed. These changes suggest a re-evaluation of the company's strategic outlook or operational metrics, although the specific content of the new narrative is not detailed in the available data. From a market perspective, AHR's calculated market share percentage saw a slight decline. The company's share percentage dropped from approximately 0.0090% to 0.0089%, representing a decrease of 1.41%. This minor contraction in market share, while small in absolute terms, aligns with the broader theme of shifting perceptions and investor activity surrounding the stock during this period. Despite these specific changes in holder activity and analytical metrics, the overall assessment indicates no material change versus prior analysis when considering the broader schema. The company continues to be tracked with 33 top holders, though it currently has no listed officers, analysts, or index memberships in the provided dataset. The combination of the holder's rapid entry and exit, alongside the revised analytical narrative, suggests a dynamic but ultimately stable underlying profile for American Healthcare REIT, Inc. as of the latest reporting dates.

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    American Healthcare REIT, Inc. (NYSE: AHR) is a diversified specialized real estate investment trust that generates revenue primarily through rental income. The company is headquartered in the United States and operates within the healthcare real estate sector. As no specific operating segments or geographic breakdowns are provided, the firm is described at the industry level as a specialized REIT focused on healthcare properties. Its common stock is listed on the New York Stock Exchange under the ticker symbol AHR.

    Classification99 %
    SectorReal Estate
    Industry groupDiversified Specialized REITs
    AI synthesis
    GENERATED

    American Healthcare REIT, Inc. (AHR) is currently classified as Equity REITs within Real Estate Investment Trusts (Real Estate). Classification confidence: 0.98 (rule-based classification). Capital structure on the latest snapshot: total assets 5,598,658,000 USD, total equity 3,481,675,000, short-term debt 0, long-term debt 0. Net cash position is approximately 119,380,000 USD. Self-calculated market cap is 10,597,773,294 USD (market_price × shares_outstanding_diluted). Profitability profile: revenue 609,767,000, gross profit 0, operating income 125,503,000, net income 23,713,000. Return on equity ~2.0%. Return on assets ~1.2%. Operating-cash-flow to net-income ratio is 4.22. Risk profile from automated assessment: liquidity risk low, dilution risk medium. Flags: Source documents mention dilution or offering risk.. Recent news context: [TRIGGER] allocator_boost: allocator_boost (allocator) on AHR — watcher=allocator; producer_version=ws49-p2a-v1; plan_date=2026-07-26; rank=28; ev=8.315025; company_id=7a68ef9d-4658-4b3e-9801-777a180eea0d; jurisdiction=US; term_contributions={'event_proximity': 2.01096, 'gradability': 2.0, 'staleness': 3.610918, 'credibility_interest': 0.693147}; days_since_analysis=36; pending_promises=1; reason=Allocator coverage boost rank #28 EV=8.315025 for AHR (hot+stale; days_since=36); contributing_watchers=allocator (source=allocator; url=allocator:2026-07-26:AHR). Additional context: allocator_boost: watcher=allocator; producer_version=ws49-p2a-v1; plan_date=2026-07-26; rank=28; ev=8.315025; company_id=7a68ef9d-4658-4b3e-9801-777a180eea0d; jurisdiction=US; term_contributions={'event_proximity': 2.01096, 'gradability': 2.0, 'staleness': 3.610918, 'credibility_interest': 0.693147}; days_since_analysis=36; pending_promises=1; reason=Allocator coverage boost rank #28 EV=8.315025 for AHR (hot+stale; days_since=36); contributing_watchers=allocator.

    American Healthcare REIT, Inc. (AHR) experienced a significant fluctuation in its shareholder base, marked by a major holder change involving investor ID 587. This investor initially increased their position from 130 shares to 5,382 shares, a move detected on June 25, 2026, which represented a substantial rise in their portfolio weight. However, this accumulation was short-lived, as the same investor subsequently reduced their holding back to 130 shares, a reversal detected on June 21, 2026. These rapid, opposing adjustments highlight a period of volatility in institutional positioning for the REIT. Concurrently, the company's analytical profile underwent moderate revisions. The AI-driven narrative and conclusion regarding AHR were updated, with a similarity score of 0.546 indicating a notable shift in the underlying thesis. Additionally, the key takeaways associated with the analysis were adjusted, with two points added and two removed. These changes suggest a re-evaluation of the company's strategic outlook or operational metrics, although the specific content of the new narrative is not detailed in the available data. From a market perspective, AHR's calculated market share percentage saw a slight decline. The company's share percentage dropped from approximately 0.0090% to 0.0089%, representing a decrease of 1.41%. This minor contraction in market share, while small in absolute terms, aligns with the broader theme of shifting perceptions and investor activity surrounding the stock during this period. Despite these specific changes in holder activity and analytical metrics, the overall assessment indicates no material change versus prior analysis when considering the broader schema. The company continues to be tracked with 33 top holders, though it currently has no listed officers, analysts, or index memberships in the provided dataset. The combination of the holder's rapid entry and exit, alongside the revised analytical narrative, suggests a dynamic but ultimately stable underlying profile for American Healthcare REIT, Inc. as of the latest reporting dates.

    Key takeaways
    • Observed GAAP P/E is about 151.82x.
    • Return on equity is about 2.0%.
    • Debt to equity is about 0.0x.
    • [TRIGGER] allocator_boost: allocator_boost (allocator) on AHR — watcher=allocator; producer_version=ws49-p2a-v1; plan_date=2026-07-26; rank=28; ev=8.315025; company_id=7a68ef9d-4658-4b3e-9801-777a180eea0d; jurisdiction=US; term_contributions={'event_proximity': 2.01096, 'gradability': 2.0, 'staleness': 3.610918, 'credibility_interest': 0.693147}; days_since_analysis=36; pending_promises=1; reason=Allocator coverage boost rank #28 EV=8.315025 for AHR (hot+stale; days_since=36); contributing_watchers=allocator (source=allocator; url=allocator:2026-07-26:AHR)
    • 10-Q Q1 0001632970 --12-31 false 0 0 5 1 http://americanhealthcarereit.com/20260331#ChiefExecutiveOfficerAndPresidentMember five days 0001632970 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001632970 ahr:IntegratedSeniorHealthCampusesMember 2025-12-31 0001632970 ahr:The2026ATMOfferingMember 2026-02-27 2026-02-27 0001632970 us-gaap:RetainedEarningsMember 2025-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:SHOPMember ahr:MedicaidMember 2025-01-01 2025-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:PrivateandOtherPayorsMember 2025-12-31 0001632970 ahr:November2025OfferingForwardSalesAgreementMember 2026-01-01 2026-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:SHOPMember us-gaap:TransferredOverTimeMember 2026-01-01 2026-03-31 0001632970 2026-05-04 0001632970 ahr:IntegratedSeniorHealthCampusesMember 2025-01-01 2025-03-31 0001632970 us-gaap:NoncontrollingInterestMember 2026-03-31 0001632970 us-gaap:EmployeeStockMember ahr:A2024StockPurchasePlanMember 2024-12-31 0001632970 us-gaap:CommonStockMember 2025-12-31 0001632970 ahr:RedeemableLimitedPartnershipUnitsMember 2025-01-01 2025-03-31 0001632970 us-gaap:NoncontrollingInterestMember 2024-12-31 0001632970 ahr:ResidentFeesandServicesMember ahr:SHOPMember us-gaap:TransferredAtPointInTimeMember 2026-01-01 2026-03-31 0001632970 us-gaap:AllOtherSegmentsMember 2026-03-31 0001632970 ahr:TripleNetLeasedPropertiesMember 2026-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:SHOPMember ahr:MedicareAdvantageMember 2025-01-01 2025-03-31 0001632970 ahr:MortgageLoansPayableNetMember 2026-03-31 0001632970 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001632970 ahr:ATMOfferingMember us-gaap:SubsequentEventMember 2026-04-01 2026-04-01 0001632970 ahr:ResidentFeesandServicesMember ahr:IntegratedSeniorHealthCampusesMember 2025-01-01 2025-03-31 0001632970 ahr:A2024CreditAgreementMember ahr:SeniorUnsecuredTermLoanFacilityMember 2026-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:IntegratedSeniorHealthCampusesMember us-gaap:TransferredOverTimeMember 2025-01-01 2025-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:SHOPMember 2025-01-01 2025-03-31 0001632970 us-gaap:ParentMember 2026-01-01 2026-03-31 0001632970 ahr:Swap3.51InterestRateMember us-gaap:NondesignatedMember 2026-03-31 0001632970 ahr:OutpatientMedicalMember 2025-01-01 2025-03-31 0001632970 us-gaap:RestrictedStockMember ahr:TwoThousandFifteenIncentivePlanMember srt:MaximumMember 2026-01-01 2026-03-31 0001632970 us-gaap:AboveMarketLeasesMember 2025-01-01 2025-03-31 0001632970 us-gaap:RetainedEarningsMember 2024-12-31 0001632970 ahr:A2024CreditAgreementMember us-gaap:StandbyLettersOfCreditMember 2025-12-31 0001632970 ahr:A2024CreditAgreementMember ahr:SeniorUnsecuredTermLoanFacilityMember 2024-02-14 2024-02-14 0001632970 ahr:BelowMarketLeaseMember 2026-01-01 2026-03-31 0001632970 srt:MinimumMember ahr:CommitmentUtilizationScenario1Member 2024-02-14 0001632970 us-gaap:NoncontrollingInterestMember 2025-12-31 0001632970 srt:MinimumMember 2026-03-31 0001632970 us-gaap:NondesignatedMember 2025-12-31 0001632970 ahr:Swap3.51InterestRateMember us-gaap:NondesignatedMember 2025-12-31 0001632970 ahr:The2025ATMOfferingMember 2025-08-08 2025-08-08 0001632970 us-gaap:RevolvingCreditFacilityMember ahr:A2024CreditAgreementMember 2025-12-31 0001632970 ahr:TripleNetLeasedPropertiesMember 2026-01-01 2026-03-31 0001632970 ahr:IntegratedSeniorHealthCampusesMember 2026-01-01 2026-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:MedicareAdvantageMember 2025-01-01 2025-03-31 0001632970 us-gaap:RevolvingCreditFacilityMember ahr:A2025TrilogyCreditFacilityMember 2025-03-02 0001632970 us-gaap:NonUsMember 2025-12-31 0001632970 ahr:ResidentFeesandServicesMember ahr:SHOPMember ahr:MedicareAdvantageMember 2026-01-01 2026-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:PrivateandOtherPayorsMember ahr:IntegratedSeniorHealthCampusesMember 2026-01-01 2026-03-31 0001632970 us-gaap:RetainedEarningsMember 2025-12-31 0001632970 ahr:ResidentFeesandServicesMember us-gaap:TransferredAtPointInTimeMember 2026-01-01 2026-03-31 0001632970 ahr:ForwardSaleAgreementsMember 2026-01-01 2026-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:IntegratedSeniorHealthCampusesMember 2026-01-01 2026-03-31 0001632970 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001632970 ahr:ForwardSaleAgreementsMember 2025-01-01 2025-03-31 0001632970 ahr:ResidentFeesandServicesMember 2025-12-31 0001632970 us-gaap:SubsequentEventMember ahr:CreditFacilityMember 2026-04-01 0001632970 us-gaap:NoncontrollingInterestMember 2026-01-01 2026-03-31 0001632970 2026-03-31 0001632970 us-gaap:RevolvingCreditFacilityMember ahr:A2025TrilogyCreditFacilityMember 2025-12-31 0001632970 us-gaap:AboveMarketLeasesMember 2025-12-31 0001632970 ahr:TwoThousandTwentySixAssetAcquisitionsMember 2026-01-01 2026-03-31 0001632970 country:US 2026-01-01 2026-03-31 0001632970 us-gaap:RestrictedStockUnitsRSUMember ahr:A2025ManagerEquityPlanMember 2026-03-31 0001632970 ahr:CertificatesOfNeedMember 2026-03-31 0001632970 ahr:A2024CreditAgreementMember us-gaap:LineOfCreditMember 2024-02-14 0001632970 ahr:NewCoSellersMember 2025-01-01 2025-12-31 0001632970 ahr:SeniorUnsecuredRevolvingCreditFacilityMember ahr:A2024CreditAgreementMember 2024-02-14 0001632970 us-gaap:LandAndLandImprovementsMember 2026-03-31 0001632970 us-gaap:EmployeeStockMember ahr:A2024StockPurchasePlanMember 2024-01-01 2024-12-31 0001632970 ahr:GeneralPartnershipMember 2025-01-01 2025-12-31 0001632970 us-gaap:NonUsMember 2026-03-31 0001632970 2026-03-31 2026-03-31 0001632970 2025-03-31 0001632970 us-gaap:NondesignatedMember ahr:Swap374InterestRateMember 2026-03-31 0001632970 ahr:A2024CreditAgreementMember us-gaap:StandbyLettersOfCreditMember 2026-03-31 0001632970 srt:MaximumMember 2026-03-31 0001632970 ahr:ResidentFeesandServicesMember 2025-01-01 2025-03-31 0001632970 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001632970 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001632970 us-gaap:RestrictedStockUnitsRSUMember ahr:TwoThousandFifteenIncentivePlanMember 2026-01-01 2026-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:SHOPMember ahr:MedicareMember 2026-01-01 2026-03-31 0001632970 us-gaap:LeasesAcquiredInPlaceMember 2025-12-31 0001632970 ahr:TimeBasedUnitMember us-gaap:RestrictedStockUnitsRSUMember 2025-01-01 2025-03-31 0001632970 ahr:TwoThousandFifteenIncentivePlanMember us-gaap:CommonStockMember 2023-06-15 0001632970 ahr:ResidentFeesandServicesMember ahr:MedicareMember 2025-01-01 2025-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:MedicareMember 2025-12-31 0001632970 us-gaap:NondesignatedMember ahr:Swap441InterestRateMember 2026-03-31 0001632970 ahr:TwoThousandTwentySixAssetAcquisitionsMember 2026-03-31 0001632970 us-gaap:RestrictedStockUnitsRSUMember ahr:A2025ManagerEquityPlanMember 2026-01-01 2026-03-31 0001632970 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-03-31 0001632970 ahr:NewCoSellersMember 2025-12-31 2025-12-31 0001632970 us-gaap:NondesignatedMember 2026-03-31 0001632970 us-gaap:ParentMember 2024-12-31 0001632970 us-gaap:CommonStockMember 2026-03-31 0001632970 us-gaap:RestrictedStockMember ahr:TwoThousandFifteenIncentivePlanMember srt:MinimumMember 2026-01-01 2026-03-31 0001632970 us-gaap:CommonStockMember 2024-12-31 0001632970 us-gaap:AboveMarketLeasesMember 2026-01-01 2026-03-31 0001632970 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001632970 us-gaap:RestrictedStockUnitsRSUMember 2026-03-31 0001632970 ahr:SHOPMember 2025-12-31 0001632970 ahr:TwoThousandTwentySixAssetAcquisitionsMember ahr:SanRafaelCAMember 2026-01-01 2026-03-31 0001632970 2026-01-01 2026-03-31 0001632970 us-gaap:RestrictedStockUnitsRSUMember 2026-01-01 2026-03-31 0001632970 ahr:ResidentFeesandServicesMember us-gaap:TransferredOverTimeMember 2025-01-01 2025-03-31 0001632970 ahr:IntegratedSeniorHealthCampusesMember 2026-03-31 0001632970 ahr:CertificatesOfNeedMember 2025-12-31 0001632970 us-gaap:NonUsMember 2026-01-01 2026-03-31 0001632970 srt:MaximumMember ahr:CommitmentUtilizationScenario1Member 2024-02-14 0001632970 ahr:ResidentFeesandServicesMember ahr:MedicaidMember 2026-01-01 2026-03-31 0001632970 us-gaap:ParentMember 2025-01-01 2025-03-31 0001632970 ahr:ATMOfferingMember 2026-03-31 2026-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:PrivateandOtherPayorsMember ahr:IntegratedSeniorHealthCampusesMember 2025-01-01 2025-03-31 0001632970 us-gaap:TradeNamesMember 2026-03-31 0001632970 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001632970 2025-12-31 0001632970 ahr:ResidentFeesandServicesMember ahr:PrivateandOtherPayorsMember 2026-01-01 2026-03-31 0001632970 ahr:ResidentFeesandServicesMember us-gaap:TransferredAtPointInTimeMember ahr:IntegratedSeniorHealthCampusesMember 2025-01-01 2025-03-31 0001632970 ahr:TermLoansMember us-gaap:SubsequentEventMember ahr:CreditFacilityMember 2026-04-01 0001632970 us-gaap:RestrictedStockUnitsRSUMember ahr:A2025ManagerEquityPlanMember 2025-12-31 0001632970 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001632970 ahr:November2025OfferingForwardSalesAgreementMember 2026-03-31 0001632970 us-gaap:NonUsMember 2025-01-01 2025-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:MedicaidMember 2025-12-31 0001632970 us-gaap:RestrictedStockUnitsRSUMember ahr:TwoThousandFifteenIncentivePlanMember srt:MaximumMember 2026-01-01 2026-03-31 0001632970 ahr:RedeemableLimitedPartnershipUnitsMember 2026-01-01 2026-03-31 0001632970 ahr:OutpatientMedicalMember 2026-01-01 2026-03-31 0001632970 country:US 2026-03-31 0001632970 ahr:BuildingImprovementsAndConstructionInProcessMember 2025-12-31 0001632970 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001632970 ahr:ResidentFeesandServicesMember ahr:IntegratedSeniorHealthCampusesMember ahr:MedicaidMember 2025-01-01 2025-03-31 0001632970 ahr:A2024CreditAgreementMember us-gaap:LineOfCreditMember 2025-12-31 0001632970 ahr:SHOPMember 2026-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:SHOPMember ahr:MedicareMember 2025-01-01 2025-03-31 0001632970 us-gaap:EmployeeStockMember ahr:A2024StockPurchasePlanMember 2026-03-31 0001632970 us-gaap:EmployeeStockMember ahr:A2024StockPurchasePlanMember 2026-01-01 2026-03-31 0001632970 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001632970 ahr:A2025ManagerEquityPlanMember 2025-12-31 0001632970 stpr:IN 2026-03-31 0001632970 ahr:TimeBasedUnitMember us-gaap:RestrictedStockUnitsRSUMember 2026-01-01 2026-03-31 0001632970 ahr:ATMOfferingForwardSalesAgreementMember 2026-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:MedicaidMember 2025-01-01 2025-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:IntegratedSeniorHealthCampusesMember ahr:MedicareAdvantageMember 2025-01-01 2025-03-31 0001632970 us-gaap:RestrictedStockUnitsRSUMember 2025-12-31 0001632970 ahr:InvestmentsNetMember 2015-10-15 0001632970 us-gaap:RevolvingCreditFacilityMember ahr:A2025TrilogyCreditFacilityMember 2026-03-31 0001632970 us-gaap:FurnitureAndFixturesMember 2026-03-31 0001632970 us-gaap:ParentMember 2025-12-31 0001632970 ahr:November2025OfferingForwardSalesAgreementMember 2025-11-24 0001632970 ahr:ResidentFeesandServicesMember us-gaap:TransferredAtPointInTimeMember ahr:IntegratedSeniorHealthCampusesMember 2026-01-01 2026-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:MedicareAdvantageMember 2026-01-01 2026-03-31 0001632970 ahr:ResidentFeesandServicesMember 2026-03-31 0001632970 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001632970 ahr:BelowMarketLeaseMember 2026-03-31 0001632970 us-gaap:RestrictedStockMember 2026-01-01 2026-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:SHOPMember ahr:MedicaidMember 2026-01-01 2026-03-31 0001632970 ahr:A2024CreditAgreementMember us-gaap:LineOfCreditMember 2026-03-31 0001632970 us-gaap:RestrictedStockUnitsRSUMember ahr:TwoThousandFifteenIncentivePlanMember 2026-03-31 0001632970 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001632970 ahr:ResidentFeesandServicesMember ahr:SHOPMember us-gaap:TransferredOverTimeMember 2025-01-01 2025-03-31 0001632970 us-gaap:LeasesAcquiredInPlaceMember 2026-03-31 0001632970 us-gaap:RestrictedStockUnitsRSUMember ahr:TwoThousandFifteenIncentivePlanMember 2025-01-01 2025-03-31 0001632970 ahr:SHOPMember 2026-01-01 2026-03-31 0001632970 us-gaap:LandAndLandImprovementsMember 2025-12-31 0001632970 2025-01-01 2025-03-31 0001632970 ahr:A2024CreditAgreementMember ahr:SeniorUnsecuredTermLoanFacilityMember 2024-02-14 0001632970 ahr:The2025ATMOfferingMember 2026-02-27 2026-02-27 0001632970 us-gaap:NoncontrollingInterestMember 2025-01-01 2025-03-31 0001632970 ahr:CommitmentUtilizationScenario2Member srt:MaximumMember 2024-02-14 0001632970 stpr:OH 2026-03-31 0001632970 ahr:PerformanceBasedUnitMember us-gaap:RestrictedStockUnitsRSUMember 2025-01-01 2025-03-31 0001632970 ahr:TripleNetLeasedPropertiesMember 2025-12-31 0001632970 ahr:A2025TrilogyCreditFacilityMember ahr:OneMonthTermSOFRMember us-gaap:LineOfCreditMember 2025-10-31 2025-10-31 0001632970 us-gaap:ParentMember 2025-03-31 0001632970 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001632970 ahr:GeneralPartnershipMember 2026-01-01 2026-03-31 0001632970 ahr:Swap441InterestRateMember us-gaap:NondesignatedMember 2025-12-31 0001632970 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001632970 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001632970 2024-12-31 0001632970 ahr:ATMOfferingMember us-gaap:SubsequentEventMember 2026-04-01 0001632970 us-gaap:AllOtherSegmentsMember 2025-12-31 0001632970 us-gaap:CommonStockMember 2025-03-31 0001632970 ahr:SeniorUnsecuredRevolvingCreditFacilityMember ahr:A2024CreditAgreementMember 2024-02-14 2024-02-14 0001632970 ahr:OutpatientMedicalMember 2026-03-31 0001632970 country:US 2025-01-01 2025-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:MedicareMember 2026-03-31 0001632970 us-gaap:ParentMember 2026-03-31 0001632970 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001632970 country:US 2025-12-31 0001632970 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-01-01 2026-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:IntegratedSeniorHealthCampusesMember ahr:MedicaidMember 2026-01-01 2026-03-31 0001632970 ahr:BelowMarketLeaseMember 2025-12-31 0001632970 us-gaap:SubsequentEventMember ahr:CreditFacilityMember 2026-04-01 2026-04-01 0001632970 ahr:A2024CreditAgreementMember us-gaap:StandbyLettersOfCreditMember 2024-12-31 0001632970 ahr:ResidentFeesandServicesMember us-gaap:TransferredAtPointInTimeMember 2025-01-01 2025-03-31 0001632970 us-gaap:CommonStockMember 2026-03-31 0001632970 us-gaap:RestrictedStockMember 2025-12-31 0001632970 ahr:ResidentFeesandServicesMember ahr:MedicareMember 2026-01-01 2026-03-31 0001632970 ahr:GeneralPartnershipMember 2026-03-31 2026-03-31 0001632970 ahr:TwoThousandTwentySixAssetAcquisitionsMember ahr:LenexaAndOlatheKSMember 2026-01-01 2026-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:MedicareAdvantageMember 2025-12-31 0001632970 srt:MinimumMember 2025-12-31 0001632970 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:IntegratedSeniorHealthCampusesMember ahr:MedicareMember 2025-01-01 2025-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:MedicareAdvantageMember 2026-03-31 0001632970 ahr:BuildingImprovementsAndConstructionInProcessMember 2026-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:PrivateandOtherPayorsMember 2026-03-31 0001632970 ahr:RestrictedStockAwardMember us-gaap:RestrictedStockMember 2025-01-01 2025-03-31 0001632970 ahr:ATMOfferingForwardSalesAgreementMember 2026-01-01 2026-03-31 0001632970 us-gaap:EmployeeStockMember ahr:A2024StockPurchasePlanMember 2025-01-01 2025-12-31 0001632970 us-gaap:RetainedEarningsMember 2026-03-31 0001632970 us-gaap:TradeNamesMember 2025-12-31 0001632970 us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001632970 us-gaap:CommonStockMember 2025-12-31 0001632970 srt:MinimumMember ahr:CommitmentUtilizationScenario2Member 2024-02-14 0001632970 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001632970 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0001632970 ahr:ResidentFeesandServicesMember ahr:IntegratedSeniorHealthCampusesMember us-gaap:TransferredOverTimeMember 2026-01-01 2026-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:MedicaidMember 2026-03-31 0001632970 ahr:A2025TrilogyCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:FederalFundsEffectiveSwapRateMember 2025-10-31 2025-10-31 0001632970 us-gaap:RestrictedStockUnitsRSUMember ahr:A2025ManagerEquityPlanMember 2025-01-01 2025-03-31 0001632970 us-gaap:RevolvingCreditFacilityMember ahr:A2024CreditAgreementMember 2026-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:SHOPMember ahr:PrivateandOtherPayorsMember 2025-01-01 2025-03-31 0001632970 ahr:OutpatientMedicalMember 2025-12-31 0001632970 ahr:MortgageLoansPayableNetMember 2025-12-31 0001632970 us-gaap:FurnitureAndFixturesMember 2025-12-31 0001632970 us-gaap:NondesignatedMember ahr:Swap3.52InterestRateMember 2026-03-31 0001632970 ahr:SHOPMember 2025-01-01 2025-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:IntegratedSeniorHealthCampusesMember ahr:MedicareMember 2026-01-01 2026-03-31 0001632970 us-gaap:NondesignatedMember ahr:Swap3.52InterestRateMember 2025-12-31 0001632970 2025-03-01 2025-03-31 0001632970 srt:MaximumMember 2025-12-31 0001632970 us-gaap:AboveMarketLeasesMember 2026-03-31 0001632970 ahr:TwoThousandTwentySixAssetAcquisitionsMember ahr:BlueSpringsKansasCityAndRaymoreMOMember 2026-01-01 2026-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:SHOPMember us-gaap:TransferredAtPointInTimeMember 2025-01-01 2025-03-31 0001632970 ahr:November2025OfferingForwardSalesAgreementMember 2025-11-24 2025-11-24 0001632970 ahr:TripleNetLeasedPropertiesMember 2025-01-01 2025-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:SHOPMember 2026-01-01 2026-03-31 0001632970 us-gaap:RestrictedStockMember ahr:RestrictedStockAwardMember 2026-01-01 2026-03-31 0001632970 2025-12-31 2025-12-31 0001632970 ahr:ATMOfferingMember 2026-03-31 0001632970 us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001632970 us-gaap:NoncontrollingInterestMember 2025-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:IntegratedSeniorHealthCampusesMember ahr:MedicareAdvantageMember 2026-01-01 2026-03-31 0001632970 ahr:PerformanceBasedUnitMember us-gaap:RestrictedStockUnitsRSUMember 2026-01-01 2026-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:PrivateandOtherPayorsMember 2025-01-01 2025-03-31 0001632970 ahr:NewCoSellersMember 2026-01-01 2026-03-31 0001632970 ahr:ResidentFeesandServicesMember 2026-01-01 2026-03-31 0001632970 ahr:BelowMarketLeaseMember 2025-01-01 2025-03-31 0001632970 ahr:ResidentFeesandServicesMember ahr:SHOPMember ahr:PrivateandOtherPayorsMember 2026-01-01 2026-03-31 0001632970 us-gaap:RevolvingCreditFacilityMember us-gaap:SubsequentEventMember ahr:CreditFacilityMember 2026-04-01 0001632970 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001632970 us-gaap:RestrictedStockMember 2026-03-31 0001632970 ahr:A2024CreditAgreementMember 2024-02-14 2024-02-14 0001632970 ahr:A2024CreditAgreementMember ahr:SeniorUnsecuredTermLoanFacilityMember 2025-12-31 0001632970 ahr:ResidentFeesandServicesMember us-gaap:TransferredOverTimeMember 2026-01-01 2026-03-31 0001632970 us-gaap:NondesignatedMember ahr:Swap374InterestRateMember 2025-12-31 xbrli:pure ahr:Tenant ahr:Extension utr:sqft ahr:Parcel ahr:Campus ahr:State iso4217:USD xbrli:shares ahr:Mortgageloan ahr:Facilities ahr:Segment xbrli:shares iso4217:USD ahr:Facility Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.
    • CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) For the Three Months Ended March 31, 2026 and 2025 (In thousands, except share and per share amounts) (Unaudited) Three Months Ended March 31, 2026 2025 Revenues: Resident fees and services $ 609,767 $ 497,176 Real estate revenue 41,007 43,427 Total revenues 650,774 540,603 Expenses: Property operating expenses 512,171 432,423 Rental expenses 13,100 13,643 General and administrative 17,605 13,155 Transaction, transition and restructuring costs 1,971 1,837 Depreciation and amortization 67,062 41,114 Total expenses 611,909 502,172 Other income (expense): Interest expense: Interest expense, net ( 18,796 ) ( 22,945 ) Gain (loss) in fair value of derivative financial instruments 1,527 ( 750 ) Loss on dispositions of real estate investments, net — ( 359 ) Impairment of real estate investments ( 418 ) ( 21,706 ) Income (loss) from unconsolidated entities 792 ( 1,848 ) Foreign currency (loss) gain ( 819 ) 1,416 Other income, net 2,335 1,525 Total net other expense ( 15,379 ) ( 44,667 ) Income (loss) before income taxes 23,486 ( 6,236 ) Income tax benefit (expense) 525 ( 604 ) Net income (loss) 24,011 ( 6,840 ) Net (income) loss attributable to noncontrolling interests ( 298 ) 36 Net income (loss) attributable to controlling interest $ 23,713 $ ( 6,804 ) Net income (loss) per common share attributable to controlling interest: Basic $ 0.13 $ ( 0.04 ) Diluted $ 0.13 $ ( 0.04 ) Weighted average number of common shares outstanding: Basic 187,319,513 156,922,819 Diluted 187,970,438 156,922,819 Net income (loss) $ 24,011 $ ( 6,840 ) Other comprehensive (loss) income: Foreign currency translation adjustments ( 120 ) 176 Total other comprehensive (loss) income ( 120 ) 176 Comprehensive income (loss) 23,891 ( 6,664 ) Comprehensive (income) loss attributable to noncontrolling interests ( 298 ) 36 Comprehensive income (loss) attributable to controlling interest $ 23,593 $ ( 6,628 ) The accompanying notes are an integral part of these condensed consolidated financial statements.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 4

    Revenue grew at a 6.2% compound annual rate from FY2023 to FY2025, demonstrating consistent top-line expansion.

    Cash conversion ratio of 4.22 is best-in-class compared to the 1.7 cohort median, highlighting strong cash generation.

    Low leverage band with a debt-to-equity ratio of 0.62 suggests a conservative capital structure relative to peers.

    Operating income increased to $415.2 million in FY2025, reflecting improved core profitability despite net income volatility.

    BEAR CASE · 3

    Return on equity of 2.0% is well below the 4.4% median, suggesting inefficient use of shareholder capital.

    The company faces medium dilution risk, which could negatively impact per-share value for existing shareholders.

    Return on assets of 1.25% indicates low efficiency in generating profit from total asset base.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-03-31
    Q4 2025 · Quarter highlights

    Revenue $609.8M; Operating income $125.5M.

    Revenue$609.8M
    Operating income$125.5M
    Net income$23.7M
    Free cash flow—
    EPS—
    Operating cash flow$81.1M
    Financials
    Income statement
    Revenue$609.8M
    Gross profit—
    Operating income$125.5M
    Net income$23.7M
    Margins
    Gross margin—
    Operating margin20.6%
    Net margin3.9%
    FCF margin—
    Balance sheet
    Total assets$5.60B
    Total liabilities$2.08B
    Total equity$3.48B
    Cash & equivalents$119.4M
    Long-term debt—
    Cash flow
    Operating cash flow$81.1M
    CapEx—
    Free cash flow—
    SBC$4.9M
    P&L flow · revenue → net income
    Revenue $609.8MOperating costs $484.3MTax $101.8MNet income $23.7M
    Highlights
    • ▍Revenue $609.8M
    • ▍Operating income $125.5M
    • ▍Net margin 3.9%

    Valuation FY

    Market price
    $55,12
    Market cap
    $10.60B
    Enterprise valueⓘ
    $10.48B
    P/Eⓘ
    151.8x
    Non-GAAP P/Eⓘ
    —
    EV / Revenueⓘ
    5.0x
    EV / Op incomeⓘ
    25.2x
    EV / OCFⓘ
    35.6x
    P / Bⓘ
    3.4x
    P / Tangible bookⓘ
    3.4x
    Tangible book
    $3.16B
    Net cashⓘ
    $119.4M
    Current ratioⓘ
    —
    Debt / equityⓘ
    —
    ROAⓘ
    1.2%
    ROEⓘ
    2.0%
    Cash conversionⓘ
    422.0%
    CapEx / revenueⓘ
    —
    SBC / revenueⓘ
    0.7%
    Dilution ratioⓘ
    -1.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPS—no estimate—no estimate0,75
    Revenue—no estimate—no estimate2,7B USD
    Operating income—no estimate—no estimate236,4M USD
    Full-year consensus mean (period as reported by source) · consensus in USD. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Corporate eventM&A horizon
    M&A probabilityconf 3 %
    Probability
    3 %
    Base rate
    3 %
    Band
    —
    180-day horizon · target 2027-01-20 · 1,0× base rate
    No acquirer candidates identified by the signal model.
    Probabilistic model output — not investment advice. · generated 2026-07-24

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution13 analysts
    Strong buy4
    Buy8
    Hold1
    Sell0
    Strong sell0
    12-month price target$57,92 · Median $58,00
    Low $54,00High $63,00
    Operating income · consensus236,4M USD
    EPS surprise
    −44,1 %
    reported vs consensus · miss
    Revenue surprise
    −16,2 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$55,00
    Mean$60,07
    Median$60,00
    High$70,00
    Spot$55,12
    +9.0 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskMedium
    Liquidity riskLow
    Filing-based flags
    • Source documents mention dilution or offering risk.

    Benchmarks vs cohort

    Op Margin19,8 %Above median
    Net Margin3,3 %Below median
    ROE2,0 %Below median
    D/E0,00Above median
    Cash Conv4,22Best in class

    Corporate actions / M&A

    M&A probabilityconf —
    Probability
    3 %
    Base rate
    3 %
    Band
    Low
    180-day horizon · target 2027-01-20 · 1,0× base rate
    No acquirer candidates identified by the signal model.
    Corporate actionsNo corporate-action source connected yet — splits, dividends and buyback events are not tracked for this company. Honest-dim (no data fabricated).

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    Derivative transactions

    Net disposed 75 472 sh22 exercises · 12 grants6 insiders
    • Willhite Gabriel MPresident & COO · Restricted Stock Unit → Common StockAcquired 6 038grant · 2026-07-21
    • Prosky DannyDirector · Restricted Stock Units → Common StockDisposed 20 912exercise · 2026-07-21
    • Prosky DannyDirector · Restricted Stock Unit → Common StockDisposed 30 886exercise · 2026-07-21
    • Hanson Jeffrey TDirector, Chief Executive Officer · Restricted Stock Unit → Common StockAcquired 35 981grant · 2026-07-21
    • Oh Stefan K.L.Chief Investment Officer · Restricted Stock Unit → Common StockDisposed 3 185exercise · 2026-04-06
    • Willhite Gabriel MChief Operating Officer · Restricted Stock Unit → Common StockDisposed 6 768exercise · 2026-04-06
    • PEAY BRIANChief Financial Officer · Restricted Stock Units → Common StockDisposed 6 768exercise · 2026-04-06
    • Prosky DannyDirector · Restricted Stock Unit → Common StockDisposed 15 924exercise · 2026-04-06
    • Foster Mark E.EVP, GC & Secretary · Restricted Stock Unit → Common StockDisposed 2 986exercise · 2026-04-06
    • Hanson Jeffrey TDirector, Interim CEO and President · Restricted Stock Unit → Common StockAcquired 42 756grant · 2026-03-26
    • PEAY BRIANChief Financial Officer · Restricted Stock Unit → Common StockDisposed 8 195exercise · 2026-03-25
    • Foster Mark E.EVP, GC & Secretary · Restricted Stock Unit → Common StockDisposed 7 435exercise · 2026-03-25
    • Foster Mark E.EVP, GC & Secretary · Restricted Stock Unit → Common StockDisposed 3 673exercise · 2026-03-25
    • Foster Mark E.EVP, GC & Secretary · Restricted Stock Unit → Common StockAcquired 6 510grant · 2026-03-25
    • Oh Stefan K.L.Chief Investment Officer · Restricted Stock Unit → Common StockDisposed 9 151exercise · 2026-03-25
    • Oh Stefan K.L.Chief Investment Officer · Restricted Stock Unit → Common StockDisposed 5 086exercise · 2026-03-25
    • Oh Stefan K.L.Chief Investment Officer · Restricted Stock Unit → Common StockAcquired 9 510grant · 2026-03-25
    • Willhite Gabriel MChief Operating Officer · Restricted Stock Unit → Common StockDisposed 9 723exercise · 2026-03-25
    • Willhite Gabriel MChief Operating Officer · Restricted Stock Unit → Common StockDisposed 5 482exercise · 2026-03-25
    • Willhite Gabriel MChief Operating Officer · Restricted Stock Unit → Common StockAcquired 10 317grant · 2026-03-25
    • PEAY BRIANChief Financial Officer · Restricted Stock Unit → Common StockDisposed 13 727exercise · 2026-03-25
    • PEAY BRIANChief Financial Officer · Restricted Stock Unit → Common StockAcquired 15 114grant · 2026-03-25
    • Prosky DannyDirector · Restricted Stock Unit → Common StockDisposed 30 885exercise · 2026-03-25
    • Prosky DannyDirector · Restricted Stock Unit → Common StockDisposed 20 912exercise · 2026-03-25
    • Foster Mark E.EVP, GC & Secretary · Restricted Stock Unit → Common StockAcquired 5 972grant · 2026-03-12

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Regulatory filings
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    • Reference data
    How metrics are computed
    • Price To Tangible Book
      market_price / (tangible_book_value / shares_outstanding_diluted)
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Return On Equity
      net_income / total_equity
    • Enterprise Value
      market_cap - net_cash
    • Ev To Revenue
      enterprise_value / revenue
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    Source documents
    • American Healthcare REIT, Inc. company facts · 2026-07-26
    • American Healthcare REIT, Inc. 10-Q 2026-05-08 · 2026-07-26
    • American Healthcare REIT, Inc. 10-K 2026-02-27 · 2026-07-26
    • American Healthcare REIT, Inc. 10-Q 2025-11-07 · 2026-07-26
    • American Healthcare REIT, Inc. 10-Q 2025-08-08 · 2026-07-26
    • allocator_boost (allocator) on AHR · 2026-07-26
    • American Healthcare REIT Inc Market data — analyst estimates · 2026-07-26
    • American Healthcare REIT Inc Market data — ESG · 2026-07-26

    Ownership & reference

    Top holders

    • Principal Global Investors (Equity)Investment Managers · as of 2026-03-310,19 %$350M
    • Wellington Management Company, LLPInvestment Managers · as of 2026-03-310,07 %$391M
    • American Century Investment Management, Inc.Investment Managers · as of 2026-03-310,05 %$96M
    • Invesco QQQ TrustFunds · as of 2026-03-310,05 %$320M
    • AllianceBernstein L.P.Investment Managers · as of 2026-03-310,04 %$132M
    • Dimensional Fund Advisors, L.P.Investment Managers · as of 2026-03-310,03 %$127M
    • Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,02 %$141M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,02 %$305M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,02 %$1 175M
    • Nuveen LLCInvestment Managers · as of 2024-12-310,02 %$58M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,02 %$452M
    • First Trust Advisors L.P.Investment Managers · as of 2026-03-310,02 %$21M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,01 %$107M
    • Bank of New York Mellon CorpInstitutional Investor · as of 2026-03-310,01 %$75M
    • FMR LLCInstitutional Investor · as of 2026-03-310,01 %$239M
    • Victory Capital Management Inc.Investment Managers · as of 2026-03-310,01 %$17M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,01 %$76M
    • Capital Research Global InvestorsInvestment Managers · as of 2026-03-310,01 %$68M
    • LPL Financial LLCInvestment Managers · as of 2026-03-310,01 %$32M
    • T. Rowe Price Associates, Inc.Investment Managers · as of 2026-03-310,01 %$0M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,01 %$32M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$83M
    • AMERIPRISE FINANCIAL INCInstitutional Investor · as of 2026-03-310,00 %$16M
    • Raymond James & Associates, Inc.Brokerage Firms · as of 2026-03-310,00 %$10M
    • JANUS HENDERSON GROUP PLCInstitutional Investor · as of 2026-03-310,00 %$4M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,00 %$9M
    • Franklin Advisers, Inc.Investment Managers · as of 2026-03-310,00 %$8M
    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,00 %$75M
    • AQR Capital Management, LLCInvestment Managers · as of 2026-03-310,00 %$3M
    • JONES FINANCIAL COMPANIES LLLPInstitutional Investor · as of 2026-03-310,00 %$1M
    • Arrowstreet Capital, Limited PartnershipInvestment Managers · as of 2026-03-310,00 %$0M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M

    Insider activity

    Net selling0 buys · 8 sellsnet -$5,3M13 insiders · last 365d
    • Prosky DannyDirector · Common StockOther 11 283 @ $56,66$639K · 2026-07-21
    • Prosky DannyDirector · Common StockOther 59 945 @ $56,66$3,4M · 2026-07-21
    • Prosky DannyDirector · Common StockOther 30 886 · 2026-07-21
    • Prosky DannyDirector · Common StockOther 16 663 @ $56,66$944K · 2026-07-21
    • Prosky DannyDirector · Common StockOther 20 912 · 2026-07-21
    • Prosky DannyDirector · Common StockOther 2 594 · 2026-07-21
    • PEAY BRIANChief Financial Officer · Common StockSold 25 000 @ $50,70$1,3M · 2026-06-26
    • Foster Mark E.EVP, GC & Secretary · Common StockSold 2 500 @ $48,58$121K · 2026-06-24
    • O'Quinn Marvin RDirector · Common StockOther 2 594 · 2026-06-24
    • Smith Wilbur H IIIDirector · Common StockOther 2 594 · 2026-06-24
    • Streiff Mathieu B.Director · Common StockOther 2 594 · 2026-06-24
    • Flornes Brian J.Director · Common StockOther 2 594 · 2026-06-24
    • Hurley DianneDirector · Common StockOther 2 594 · 2026-06-24
    • ESTES SCOTT ADirector · Common StockOther 2 594 · 2026-06-24
    • Richardson ValerieDirector · Common StockOther 2 594 · 2026-06-24
    • Foster Mark E.EVP, GC & Secretary · Common StockSold 2 000 @ $48,32$97K · 2026-06-01
    • Willhite Gabriel MChief Operating Officer · Common StockOther 3 654 @ $48,09$176K · 2026-04-06
    • Prosky DannyDirector · Common StockOther 8 596 @ $48,09$413K · 2026-04-06
    • Prosky DannyDirector · Common StockOther 15 924 · 2026-04-06
    • PEAY BRIANChief Financial Officer · Common StockOther 3 654 @ $48,09$176K · 2026-04-06
    • PEAY BRIANChief Financial Officer · Common StockOther 6 768 · 2026-04-06
    • Willhite Gabriel MChief Operating Officer · Common StockOther 6 768 · 2026-04-06
    • Oh Stefan K.L.Chief Investment Officer · Common StockOther 1 621 @ $48,09$78K · 2026-04-06
    • Oh Stefan K.L.Chief Investment Officer · Common StockOther 3 185 · 2026-04-06
    • Foster Mark E.EVP, GC & Secretary · Common StockOther 1 612 @ $48,09$78K · 2026-04-06

    Short positioning

    21.9Mshares short+11.2% vs prior
    6.95days to cover
    53.7%short of daily vol
    5.2Kfails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    AHRCanonical
    NYSE · USD

    Intel & risk

    PredictorM&A prob3 %Full forecast →
    What changed

    no material change vs prior analysis (walked 17 fields; 4 schema-expansion field(s) excluded)

    • Narrative— → —medium
    • Conclusion— → —medium
    • Key takeaways— → —medium
    • Company share pct— → —medium
    vs prior analysis today
    peak dispatch · —
    OSINT findings
    Dilution riskMedium
    Liquidity riskLow
    Source documents mention dilution or offering risk.

    Evidence & claims

    From filings & derived data
    • Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 8.4%Derived (calculated)
    • EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 244.8%Derived (calculated)
    • Net margin (FY 2025-12-31): 3.1%Derived (calculated)
    • Total liabilities (YoY) (2025-12-31 vs 2024-12-31): -5.4%Derived (calculated)
    • Return on equity (FY 2025-12-31): 2.1%Derived (calculated)
    • Return on assets (FY 2025-12-31): 1.3%Derived (calculated)
    • Debt-to-equity (FY 2025-12-31): 0.62xDerived (calculated)
    • Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 49.7%Derived (calculated)
    • Revenue (YoY) (2025-12-31 vs 2024-12-31): 9.1%Derived (calculated)
    • Operating income (YoY) (2025-12-31 vs 2024-12-31): 14.2%Derived (calculated)
    • Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 67.2%Derived (calculated)
    • Net income (YoY) (2025-12-31 vs 2024-12-31): 298.9%Derived (calculated)
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): 20.9%Derived (calculated)
    • EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 244.8%Derived (calculated)
    • Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 46.9%Derived (calculated)
    • Total assets (annual): USD 5.43BSEC XBRL filing
    • Total liabilities (annual): USD 2.07BSEC XBRL filing
    • Interest expense (annual): USD 85.78MSEC XBRL filing
    • EPS (diluted) (annual): USD-PER-SHARES 0SEC XBRL filing
    • Pre-tax income (annual): USD 48.65MSEC XBRL filing
    • Shareholders' equity (annual): USD 3.32BSEC XBRL filing
    • Shares outstanding (annual): 185.91MSEC XBRL filing
    • Operating cash flow (annual): USD 294.44MSEC XBRL filing
    • Net income (annual): USD 70.82MSEC XBRL filing
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-07-21INSIDERProsky Danny transacted 59.9k sh — Director ~$3.40M
    2026-07-21INSIDERProsky Danny transacted 2.6k sh — Director
    2026-07-21INSIDERProsky Danny transacted 11.3k sh — Director ~$639k
    2026-07-21INSIDERProsky Danny transacted 20.9k sh — Director
    2026-07-21INSIDERProsky Danny transacted 16.7k sh — Director ~$944k
    2026-07-21INSIDERProsky Danny transacted 30.9k sh — Director
    2026-07-21INSIDERHanson Jeffrey T acquired 36.0k sh Restricted Stock Unit — Director, Chief Executive Officer
    2026-07-21INSIDERWillhite Gabriel M acquired 6.0k sh Restricted Stock Unit — President & COO
    2026-07-21INSIDERProsky Danny disposed of 30.9k sh Restricted Stock Unit — Director
    2026-07-21INSIDERProsky Danny disposed of 20.9k sh Restricted Stock Units — Director
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: ma_probability (180d)
    2026-06-26 00:00 UTCINSIDER10 insider transactions — 2026-06 · net sell $1.5M
    2026-06-26INSIDERPEAY BRIAN sold 25.0k sh — Chief Financial Officer ~$1.27M
    2026-06-25 03:10 UTCHOLDER1 institutional position change flagged (1 major)
    2026-06-24INSIDERRichardson Valerie transacted 2.6k sh — Director
    2026-06-24INSIDERO'Quinn Marvin R transacted 2.6k sh — Director
    2026-06-24INSIDERStreiff Mathieu B. transacted 2.6k sh — Director
    2026-06-24INSIDERHurley Dianne transacted 2.6k sh — Director
    2026-06-24INSIDERFlornes Brian J. transacted 2.6k sh — Director
    2026-06-24INSIDERSmith Wilbur H III transacted 2.6k sh — Director
    2026-06-24INSIDERFoster Mark E. sold 2.5k sh — EVP, GC & Secretary ~$121k
    2026-06-24INSIDERESTES SCOTT A transacted 2.6k sh — Director
    2026-06-21 02:57 UTCHOLDER1 institutional position change flagged (1 major)
    2026-06-18FILING8-K filing →
    2026-06-01INSIDERFoster Mark E. sold 2.0k sh — EVP, GC & Secretary ~$97k
    2026-05-28FILING8-K filing →
    2026-05-22FILING8-K filing →
    2026-05-21FILING424B5 filing →
    2026-05-20FILING424B5 filing →
    2026-05-08FILING10-Q filing →
    2026-05-07FILING8-K filing →
    2026-04-09FILINGDEF 14A filing →
    2026-04-07FILING8-K filing →
    2026-04-06 00:00 UTCINSIDER15 insider transactions — 2026-04 · net sell $920k 5 derivative
    2026-04-06INSIDERWillhite Gabriel M transacted 3.7k sh — Chief Operating Officer ~$176k
    2026-04-06INSIDERProsky Danny transacted 8.6k sh — Director ~$413k
    2026-04-06INSIDERProsky Danny transacted 15.9k sh — Director
    2026-04-06INSIDERPEAY BRIAN transacted 3.7k sh — Chief Financial Officer ~$176k
    2026-04-06INSIDERPEAY BRIAN transacted 6.8k sh — Chief Financial Officer
    Showing the 40 most recent of 69 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data · Reference data Premium coverage